Dr. White is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
875 Pre Emption Road
Geneva, NY 14456
Summary
- I am a board certified neurologist with multiple areas of subspecialty practice including neuro-oncology, sports neurology and movement disorders/deep brain stimulation.
Education & Training
- Massachusetts General HospitalFellowship, Innovation Fellows Program , 2019 - 2020
- Massachusetts General HospitalPost-Doctoral Fellowship, 2017 - 2019
- Dana-Farber Cancer InstituteFellowship, Neuro-Oncology, 2016 - 2019
- Massachusetts General HospitalFellowship, Neuro-Oncology, 2016 - 2019
- Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2013 - 2016
- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2012 - 2013
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2012
Certifications & Licensure
- NY State Medical License 2019 - 2025
- CO State Medical License 2021 - 2023
- MA State Medical License 2016 - 2023
- MO State Medical License 2012 - 2016
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Patient Experience Award Massachusetts General Hospital-Divison of Comprehensive Neurology, 2019-2020
- Semaan Family Foundation Neuro- Oncology Fellow Massachuestts General Hospital, 2017-2019
- Special Recognition Division of Neuro-Oncology Massachusetts General Hospital, 2018
- Join now to see all
Publications & Presentations
PubMed
- 41 citationsPhase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas.Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, Eudocia Quant Lee, Nancy Wang
Nature Communications. 2022-03-14 - 44 citationsPhase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.Priscilla K. Brastianos, Matthew R. Strickland, Eudocia Q. Lee, Nancy Wang, Justine V. Cohen
Nature Communications. 2021-10-12 - 32 citationsDetection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal FluidMichael White, Robert H. Klein, Brian A. Shaw, Albert H. Kim, Megha Subramanian
JAMA Network Open. 2021-08-02
External Links
- LinkedInhttps://www.linkedin.com/in/michael-white-md-960014125/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: